These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35890090)

  • 1. Design and Synthesis of New Pyrimidine-Quinolone Hybrids as Novel
    Díaz I; Salido S; Nogueras M; Cobo J
    Pharmaceuticals (Basel); 2022 Jun; 15(7):. PubMed ID: 35890090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Modifications of Diarylpyrimidine-quinolone Hybrids as Potent HIV-1 NNRTIs with an Improved Drug Resistance Profile.
    Mao TQ; He QQ; Chen WX; Tang GF; Chen FE; De Clercq E; Daelemans D; Pannecouque C
    Curr Pharm Des; 2016; 22(46):6982-6987. PubMed ID: 27875973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of quinoline-pyrimidine inspired hybrids as potential plasmodial inhibitors.
    Kayamba F; Malimabe T; Ademola IK; Pooe OJ; Kushwaha ND; Mahlalela M; van Zyl RL; Gordon M; Mudau PT; Zininga T; Shonhai A; Nyamori VO; Karpoormath R
    Eur J Med Chem; 2021 May; 217():113330. PubMed ID: 33744688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer's disease: Quinolotacrine hybrids.
    Sadafi Kohnehshahri M; Chehardoli G; Bahiraei M; Akbarzadeh T; Ranjbar A; Rastegari A; Najafi Z
    Mol Divers; 2022 Feb; 26(1):489-503. PubMed ID: 34491490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Route to the Synthesis of Novel Pyrazolo[1,5-a]pyrimidines and Evaluation of their Antimicrobial Activity as RNA Polymerase Inhibitors.
    Abdallah AEM; Elgemeie GH
    Med Chem; 2022; 18(9):926-948. PubMed ID: 35236270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, Cytotoxicity, ADMET and Molecular Docking Studies of Some Quinoline-Pyrimidine Hybrid Compounds: 3-(2-Amino-6-arylpyrimidin-4- yl)-4-hydroxy-1-methylquinolin-2(1H)-ones.
    Toan DN; Thanh ND; Truong MX; Van DT
    Med Chem; 2022; 18(1):36-50. PubMed ID: 33380305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cinnamide derived pyrimidine-benzimidazole hybrids as tubulin inhibitors: Synthesis, in silico and cell growth inhibition studies.
    Sana S; Reddy VG; Srinivasa Reddy T; Tokala R; Kumar R; Bhargava SK; Shankaraiah N
    Bioorg Chem; 2021 May; 110():104765. PubMed ID: 33677248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, microwave assisted synthesis, and molecular modeling study of some new 1,3,4-thiadiazole derivatives as potent anticancer agents and potential VEGFR-2 inhibitors.
    Atta-Allah SR; AboulMagd AM; Farag PS
    Bioorg Chem; 2021 Jul; 112():104923. PubMed ID: 33932767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Synthesis, biological Evaluation, and molecular docking studies of novel Pyrazolo[3,4-d]Pyrimidine derivative scaffolds as potent EGFR inhibitors and cell apoptosis inducers.
    Sherbiny FF; Bayoumi AH; El-Morsy AM; Sobhy M; Hagras M
    Bioorg Chem; 2021 Nov; 116():105325. PubMed ID: 34507234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, biological evaluation and docking studies of novel 2-substituted-4-morpholino-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine derivatives as dual PI3Kα/mTOR inhibitors.
    Lei F; Sun C; Xu S; Wang Q; OuYang Y; Chen C; Xia H; Wang L; Zheng P; Zhu W
    Eur J Med Chem; 2016 Jun; 116():27-35. PubMed ID: 27043268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactate dehydrogenase A inhibitors with a 2,8-dioxabicyclo[3.3.1]nonane scaffold: A contribution to molecular therapies for primary hyperoxalurias.
    Alejo-Armijo A; Cuadrado C; Altarejos J; Fernandes MX; Salido E; Diaz-Gavilan M; Salido S
    Bioorg Chem; 2022 Dec; 129():106127. PubMed ID: 36113265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, Synthesis and Molecular Docking Studies of Novel Indole-Pyrimidine Hybrids as Tubulin Polymerization Inhibitors.
    Hu MJ; Zhang B; Yang HK; Liu Y; Chen YR; Ma TZ; Lu L; You WW; Zhao PL
    Chem Biol Drug Des; 2015 Dec; 86(6):1491-500. PubMed ID: 26177395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, anticancer activity and docking studies of novel 4-morpholino-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine derivatives as mTOR inhibitors.
    Zhu W; Sun C; Xu S; Wu C; Wu J; Xu M; Zhao H; Chen L; Zeng W; Zheng P
    Bioorg Med Chem; 2014 Dec; 22(24):6746-54. PubMed ID: 25468038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of novel indole-pyrimidine hybrids bearing morpholine and thiomorpholine moieties.
    Diao PC; Li Q; Hu MJ; Ma YF; You WW; Hong KH; Zhao PL
    Eur J Med Chem; 2017 Jul; 134():110-118. PubMed ID: 28410492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New C2- and N3-Modified Thieno[2,3-d]Pyrimidine Conjugates with Cytotoxicity in the Nanomolar Range.
    Mavrova AT; Dimov S; Yancheva D; Rangelov M; Wesselinova D; Naydenova E
    Anticancer Agents Med Chem; 2022; 22(6):1201-1212. PubMed ID: 34315388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conventional and microwave prompted synthesis, antioxidant, anticholinesterase activity screening and molecular docking studies of new quinolone-triazole hybrids.
    Mermer A; Demirbaş N; Şirin Y; Uslu H; Özdemir Z; Demirbaş A
    Bioorg Chem; 2018 Aug; 78():236-248. PubMed ID: 29614435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, Synthesis,
    Matada GSP; Abbas N; Dhiwar PS; Basu R; Devasahayam G
    Anticancer Agents Med Chem; 2021; 21(4):451-461. PubMed ID: 32698735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of 1H-pyrrolo[2,3-d]pyrimidine-1,2,3-triazole derivatives as novel anti-tubercular agents.
    Shiva Raju K; AnkiReddy S; Sabitha G; Siva Krishna V; Sriram D; Bharathi Reddy K; Rao Sagurthi S
    Bioorg Med Chem Lett; 2019 Jan; 29(2):284-290. PubMed ID: 30497913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
    Maher M; Kassab AE; Zaher AF; Mahmoud Z
    Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and SAR studies of novel 4-methoxyphenyl pyrazole and pyrimidine derivatives as potential dual tyrosine kinase inhibitors targeting both EGFR and VEGFR-2.
    El-Naggar AM; Hassan AMA; Elkaeed EB; Alesawy MS; Al-Karmalawy AA
    Bioorg Chem; 2022 Jun; 123():105770. PubMed ID: 35395446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.